InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,297.10
(
-0.21%
)
US TECH 100
18,078.00
(
-0.21%
)
Dow Jones
39,869.38
(
-0.10%
)
Brent Oil
83.22
(
0.01%
)
Bitcoin
65,396.00
(
0.24%
)
Post# of 146215
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

xoc

Send PM Follow Ignore
Followers 13
Posts 303
Boards Moderated 0
Alias Born 04/20/2010

xoc

Re: None

Friday, 12/03/2010 8:47:42 PM

Friday, December 03, 2010 8:47:42 PM

Post# of 146215
As per a summary from John Schieszer in Oncology News International, an antiviral drug was found to retard growth of cervical cancer cells

see link below
http://www.cancernetwork.com/display/article/10165/1740257

Investigators @ German Cancer Research Center (Eberhard Antmann et al)reported ICAAC abstract TF1-1646 on effects of LMV-601, a phosphatidyl choline specific phospholipase C inhibitor being developed by Lumavita AG. Human cervical cancer cells derived from patients with high risk HPV and cervical cancer were treated in vitro with this antiviral compound, and both virus expression and growth/multiplication of the cancer was stopped. A clinical study in patients with early stage cervical cancer is scheduled to begin within the next year.

If this works with this drug, could a nanoviricide for HPV work even better?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NNVC News
More NNVC News
InvestorsHub NewsWire

FEATURED Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • May 16, 2024 8:13 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM

HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM

Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM

Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM

Start posting your company's news
Only $200 per official company press release!